NDC 33342-550 – Nintedanib esylate
Nintedanib Esylate 100 mg/1 · Capsule · Oral
Product NDC33342-550
Product details
- Brand name
- Nintedanib esylate
- Generic name
- Nintedanib esylate
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA219926
- Marketed since
- August 3, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Nintedanib Esylate 100 mg/1
Uses, dosage, side effects and warnings for Nintedanib esylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 33342-550-09 | 60 CAPSULE in 1 BOTTLE (33342-550-09) | Aug 3, 2026 |
Other Nintedanib esylate products
- 33342-551 Nintedanib Esylate 150 mg/1 · Capsule · Macleods Pharmaceuticals Limited